Editor's Note Endovascular devices used to block aneurysm blood flow are the subject of the latest recall to be designated Class 1—the most severe designation indicating serious risk of injury or death—by the US Food and Drug Administration (FDA). As detailed in the agency’s March 18 announcement, Medtronic Neurovascular is…

Read More

Editor's Note Miniaturized pacemakers implanted in neonates and infants have demonstrated reliable performance for up to two years, with no unexpected device failures, according to a March 11 article in Healio. The research, published in Circulation: Arrhythmia and Electrophysiology, suggests that these modified pacemakers could offer a viable alternative for…

Read More

Editor's Note An Australian man lived for 100 days with an artificial titanium heart, the longest duration recorded for a patient using the device, according to a March 12 report from CNN. The breakthrough marks a significant step toward using total artificial hearts as a long-term solution for patients with…

Read More

Editor's Note Surgeons recently performed open-heart surgery on an infant during a C-section to correct a congenital heart defect, according to a February 25 brief from the American College of Surgeons. Led by Dr. Sameh Said at Maria Fareri Children's Hospital, a team of specialists conducted the procedure on a…

Read More

Editor’s Note The US Food and Drug Administration (FDA) has designated Boston Scientific Corporation’s recall of Accolade Pacemaker devices a Class 1, the most severe category indicating serious risk of injury or death. According to the agency’s February 21 announcement, the recall was motivated by a manufacturing issue that could…

Read More

Editor's Note Patients aged 50 to 70 undergoing heart valve replacement may benefit from mechanical valves over biological ones, according to a new study from the University of Bristol. Healthcare-in-Europe.com reported the news February 13. As detailed in the article, short-term outcomes between the two options were similar. However, mechanical…

Read More

Editor's Note Coronary artery bypass graft (CABG) surgery and transcatheter aortic valve replacement (TAVR) generate the highest overall financial returns for US hospitals, despite not being the most profitable per procedure, according to a February 13 report in Cardiovascular Business. The article covers an analysis of Medicare data, published in…

Read More

Editor’s Note At the Society of Thoracic Surgeons (STS) annual meeting, experts urged cardiac surgeons to become more engaged in tricuspid valve treatment before transcatheter options gain too much traction according to a January 26 report in MedPage Today. With new transcatheter devices gaining FDA approval and the Centers for…

Read More

Editor's Note Research shows combining music with preoperative education not only reduces anxiety, but also enhances recovery outcomes in patients undergoing open cardiac surgery. Published January 21 in the Journal of Perianesthesia Nursing, the randomized controlled study involved 322 patients, evenly randomized into an experimental group (music and preoperative education)…

Read More

Editor's Note Black patients are less likely to receive surgery at hospitals with the lowest mortality rates despite living closer to these facilities, according to a new study examining Medicare patients undergoing coronary artery bypass grafting (CABG) from 2017 to 2019. Authors suggest that physician referral patterns may play a…

Read More